ST PETER PORT, GUERNSEY / ACCESSWIRE / October 19, 2022 / Goodbody Health Limited (AQSE:GDBY)(OTCQB:GDBYF) ("Goodbody" or the "Company"), today announces that it has signed an agreement with Allied Pharmacies Limited to join the Goodbody clinic network. The new Allied Pharmacies clinics adds 17 pharmacies that can provide a range of services including the range of diagnostic testing offered by the Goodbody clinics and other health services including ear wax micro suction. Earwax removal is no longer offered by most GPs, so patients are increasingly turning to community pharmacies for advice and treatment.
2.3 million people a year in the UK experience build-up of earwax that requires removal, according to the National Institute of Health and Care Excellence (Nice)*. A build-up of earwax in the ear canal can cause hearing loss and discomfort, contributes to infections, and can exacerbate stress, social isolation, and depression.
The painless wax removal procedure can be completed in one 30 minute appointment through their local Goodbody clinic with customers able to book online through the Goodbody website. The micro suction earwax removal service uses a small vacuum to safely and gently remove stubborn ear wax using a high-definition digital otoscopy system - the world's first all-in-one ear and hearing healthcare assessment device, at an Allied Pharmacies clinic.
Marc Howells, Chief Executive Officer, says; "We are delighted to be working together with Allied Pharmacies group of community pharmacies, whom we welcome to our Goodbody network. The widening of our network will drive more footfall to local pharmacies and help more customers improve their Wellbeing."
The directors of the Company accept responsibility for the contents of this announcement
Cautionary Statement Regarding Forward-Looking Statements
Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release. This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Goodbody Health's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" "plan is" or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur", "will be achieved" or "shortly". The forward-looking information and forward-looking statements contained herein include, but are not limited to: patients are increasingly turning to community pharmacies for advice and treatment;
Although Goodbody Health believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, there is no guarantee that; the widening of our network will drive more footfall to local pharmacies and help more customers improve their Wellbeing.
Goodbody Health does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws
On behalf of the Board of Directors,
Contact Information:
Marc Howells
Chief Executive Officer
+44 (0)20 7971 1255
enquiries@goodbodyhealth.com
www.goodbodyhealth.com
Anne Tew
Chief Financial Officer
832-308-4975
enquiries@goodbodyhealth.com
www.goodbodyhealth.com
SOURCE: Goodbody Health Limited
View source version on accesswire.com:
https://www.accesswire.com/720858/Agreement-with-Allied-Pharmacies-Adds-17-Clinics
